Cargando…
Reduced Oxidative Stress and Enhanced FGF21 Formation in Livers of Endurance-Exercised Rats with Diet-Induced NASH
Non-alcoholic fatty liver diseases (NAFLD) including the severe form with steatohepatitis (NASH) are highly prevalent ailments to which no approved pharmacological treatment exists. Dietary intervention aiming at 10% weight reduction is efficient but fails due to low compliance. Increase in physical...
Autores principales: | Henkel, Janin, Buchheim-Dieckow, Katja, Castro, José P., Laeger, Thomas, Wardelmann, Kristina, Kleinridders, André, Jöhrens, Korinna, Püschel, Gerhard P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893460/ https://www.ncbi.nlm.nih.gov/pubmed/31717358 http://dx.doi.org/10.3390/nu11112709 |
Ejemplares similares
-
Augmented liver inflammation in a microsomal prostaglandin E synthase 1 (mPGES-1)-deficient diet-induced mouse NASH model
por: Henkel, Janin, et al.
Publicado: (2018) -
Soybean Oil-Derived Poly-Unsaturated Fatty Acids Enhance Liver Damage in NAFLD Induced by Dietary Cholesterol
por: Henkel, Janin, et al.
Publicado: (2018) -
FGF19 and FGF21: In NASH we trust
por: Talukdar, Saswata, et al.
Publicado: (2020) -
Dietary cholesterol does not break your heart but kills your liver
por: Püschel, Gerhard P., et al.
Publicado: (2019) -
FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human
por: Henriksson, Emma, et al.
Publicado: (2020)